Table 4 Efficacy of a single oral dose of Simparica Trio™ and afoxolaner+ milbemycin oxime against natural flea infestations on dogs presented as veterinary patients in Europe: percentage of flea allergic dermatitis dogs with clinical signs
Treatment group | Assessment day | n | Pruritus | Erythema | Scaling | Alopecia from self-trauma | Dermatitis/Pyodermatitis |
|---|---|---|---|---|---|---|---|
Simparica Trio™ | − 1 or 0 | 10 | 100 | 60.0 | 70.0 | 60.0 | 30.0 |
14 ± 5 | 10 | 30.0 | 10.0 | 30.0 | 10.0 | 10.0 | |
30 ± 5 | 10 | 20.0 | 10.0 | 10.0 | 0 | 10.0 | |
Afoxolaner + Milbemycin oxime | − 1 or 0 | 9 | 100 | 88.9 | 88.9 | 55.6 | 55.6 |
14 ± 5 | 8 | 37.5 | 12.5 | 50.0 | 37.5 | 12.5 | |
30 ± 5 | 8 | 12.5 | 0 | 25.0 | 0 | 0 |